(Q73351649)
Statements
A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency (English)
Janssen YJ
Helmerhorst F
Frölich M